Shares in the Auckland-based drugmaker, AFT Pharmaceutical, have had a strong debut on the New Zealand stock exchange, trading at a 14 percent premium to their issue price.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
